vs
MONARCH CASINO & RESORT INC（MCRI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是MONARCH CASINO & RESORT INC的1.5倍（$207.3M vs $136.6M），MONARCH CASINO & RESORT INC净利率更高（20.2% vs -62.0%，领先82.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.9%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 3.2%）
君主赌场度假村集团是美国知名博彩度假企业，旗下运营位于内华达州里诺的亚特兰蒂斯赌场度假水疗中心。该物业设有三座酒店塔楼，共824间客房及套房，博彩区面积达64814平方英尺，是里诺当地盈利水平领先、定位高端的度假目的地，累计已投入近1.5亿美元用于设施升级。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MCRI vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $136.6M | $207.3M |
| 净利润 | $27.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 25.6% | -54.7% |
| 净利率 | 20.2% | -62.0% |
| 营收同比 | 8.9% | 25.9% |
| 净利润同比 | 38.9% | 3.5% |
| 每股收益（稀释后） | $1.52 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $136.6M | — | ||
| Q4 25 | $140.0M | $207.3M | ||
| Q3 25 | $142.8M | $159.9M | ||
| Q2 25 | $136.9M | $166.5M | ||
| Q1 25 | $125.4M | $139.3M | ||
| Q4 24 | $134.5M | $164.6M | ||
| Q3 24 | $137.9M | $139.5M | ||
| Q2 24 | $128.1M | $147.0M |
| Q1 26 | $27.6M | — | ||
| Q4 25 | $22.9M | $-128.6M | ||
| Q3 25 | $31.6M | $-180.4M | ||
| Q2 25 | $27.0M | $-115.0M | ||
| Q1 25 | $19.9M | $-151.1M | ||
| Q4 24 | $4.2M | $-133.2M | ||
| Q3 24 | $27.6M | $-133.5M | ||
| Q2 24 | $22.7M | $-131.6M |
| Q1 26 | — | — | ||
| Q4 25 | 20.8% | — | ||
| Q3 25 | 26.7% | — | ||
| Q2 25 | 25.5% | — | ||
| Q1 25 | 20.2% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 25.6% | — | ||
| Q2 24 | 23.0% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 21.3% | -54.7% | ||
| Q3 25 | 27.1% | -106.9% | ||
| Q2 25 | 25.8% | -64.8% | ||
| Q1 25 | 20.4% | -102.6% | ||
| Q4 24 | 3.1% | -74.3% | ||
| Q3 24 | 25.5% | -94.6% | ||
| Q2 24 | 22.9% | -79.1% |
| Q1 26 | 20.2% | — | ||
| Q4 25 | 16.4% | -62.0% | ||
| Q3 25 | 22.1% | -112.8% | ||
| Q2 25 | 19.7% | -69.0% | ||
| Q1 25 | 15.8% | -108.5% | ||
| Q4 24 | 3.1% | -80.9% | ||
| Q3 24 | 20.0% | -95.7% | ||
| Q2 24 | 17.7% | -89.5% |
| Q1 26 | $1.52 | — | ||
| Q4 25 | $1.25 | $-1.28 | ||
| Q3 25 | $1.69 | $-1.81 | ||
| Q2 25 | $1.44 | $-1.17 | ||
| Q1 25 | $1.05 | $-1.57 | ||
| Q4 24 | $0.25 | $-1.34 | ||
| Q3 24 | $1.47 | $-1.40 | ||
| Q2 24 | $1.19 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $120.1M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $549.8M | $-80.0M |
| 总资产 | $725.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $120.1M | — | ||
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M |
| Q1 26 | $549.8M | — | ||
| Q4 25 | $537.7M | $-80.0M | ||
| Q3 25 | $558.4M | $9.2M | ||
| Q2 25 | $539.2M | $151.3M | ||
| Q1 25 | $535.6M | $144.2M | ||
| Q4 24 | $517.7M | $255.0M | ||
| Q3 24 | $513.3M | $346.8M | ||
| Q2 24 | $498.4M | $432.4M |
| Q1 26 | $725.2M | — | ||
| Q4 25 | $712.8M | $1.5B | ||
| Q3 25 | $725.4M | $1.2B | ||
| Q2 25 | $705.8M | $1.3B | ||
| Q1 25 | $712.1M | $1.3B | ||
| Q4 24 | $691.6M | $1.5B | ||
| Q3 24 | $671.1M | $1.5B | ||
| Q2 24 | $672.4M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $38.1M | $-99.8M | ||
| Q3 25 | $56.0M | $-91.4M | ||
| Q2 25 | $34.1M | $-108.3M | ||
| Q1 25 | $36.5M | $-166.5M | ||
| Q4 24 | $37.8M | $-79.3M | ||
| Q3 24 | $40.3M | $-67.0M | ||
| Q2 24 | $24.3M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | $32.2M | $-100.8M | ||
| Q3 25 | $53.5M | $-92.7M | ||
| Q2 25 | $26.0M | $-110.7M | ||
| Q1 25 | $16.6M | $-167.8M | ||
| Q4 24 | $26.2M | $-79.5M | ||
| Q3 24 | $35.4M | $-68.6M | ||
| Q2 24 | $11.0M | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | 23.0% | -48.6% | ||
| Q3 25 | 37.5% | -58.0% | ||
| Q2 25 | 19.0% | -66.5% | ||
| Q1 25 | 13.3% | -120.5% | ||
| Q4 24 | 19.5% | -48.3% | ||
| Q3 24 | 25.7% | -49.2% | ||
| Q2 24 | 8.5% | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 0.5% | ||
| Q3 25 | 1.7% | 0.8% | ||
| Q2 25 | 5.9% | 1.5% | ||
| Q1 25 | 15.8% | 1.0% | ||
| Q4 24 | 8.6% | 0.1% | ||
| Q3 24 | 3.6% | 1.2% | ||
| Q2 24 | 10.4% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.66× | — | ||
| Q3 25 | 1.77× | — | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 8.98× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | 1.07× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MCRI
| Casino | $79.7M | 58% |
| Food and beverage | $31.7M | 23% |
| Hotel | $19.0M | 14% |
| Other | $6.1M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
